Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia (Q34230967)

31 July 2017

Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia (English)

1 reference

31 July 2017

0 references

0 references

0 references

7

William W Busse

1 reference

31 July 2017

Michel Laviolette

1

1 reference

31 July 2017

David L Gossage

2

1 reference

31 July 2017

Gail Gauvreau

3

1 reference

31 July 2017

Richard Leigh

4

1 reference

31 July 2017

Ron Olivenstein

5

1 reference

31 July 2017

Rohit Katial

6

1 reference

31 July 2017

Sally Wenzel

8

1 reference

31 July 2017

Yanping Wu

9

1 reference

31 July 2017

Vivekananda Datta

10

1 reference

31 July 2017

Roland Kolbeck

11

1 reference

31 July 2017

Nestor A Molfino

12

1 reference

31 July 2017

language of work or name

English

0 references

publication date

16 July 2013

1 reference

The Journal of Allergy and Clinical Immunology

31 July 2017

1 reference

31 July 2017

132

1 reference

31 July 2017

5

1 reference

31 July 2017

1086-1096.e5

1 reference

Reslizumab for Poorly Controlled, Eosinophilic Asthma

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Monoclonal antibodies and other biologic agents in the treatment of asthma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Mepolizumab and exacerbations of refractory eosinophilic asthma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Relation of perceived nasal and bronchial hyperresponsiveness to FEV1, basophil counts, and methacholine response

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

CD203c expression on human basophils is associated with asthma exacerbation

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthma.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Accumulation of basophils and their chemotactic activity in the airways during natural airway narrowing in asthmatic individuals.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172321

Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma

28 October 2018

1 reference

12 December 2020

Immunohistochemical detection of human basophils in postmortem cases of fatal asthma

1 reference

12 December 2020

Basophils in bronchial asthma with reference to reagin-type allergy

1 reference

12 December 2020

Intrasubject variability in airway inflammation in biopsies in mild to moderate stable asthma

1 reference

12 December 2020

Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils

1 reference

12 December 2020

Strategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthma

1 reference

12 December 2020

MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function

1 reference

12 December 2020

10.1016/J.JACI.2013.05.020

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference